The Rapamycin Derivative RAD001 (Everolimus) Inhibits Cell Proliferation and Interacts with the Akt-mTOR-p70S6K Pathway in Human Medullary Thyroid Carcinoma Cells

Podobné jednotky

• The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells.
  Autor: Grozinsky-Glasberg, S, a další
  Vydáno: (2010)
• Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.
  Autor: Grozinsky-Glasberg, S, a další
  Vydáno: (2008)
• The Global mTOR Inhibitor Torin1 Is More Effective than the mTORC1 Inhibitor, Everolimus, Alone or in Combination with Histone Deacetylase Inhibitors, in Suppressing Neuroendocrine Tumor Cell Proliferation
  Autor: Grozinsky-Glasberg, S, a další
  Vydáno: (2011)
• Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
  Autor: Druce, MR, a další
  Vydáno: (2009)
• Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma
  Autor: Druce, M, a další
  Vydáno: (2012)